Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
about
Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?Dual blockade of the renin-angiotensin system in diabetic nephropathy.Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda.Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fractionUsefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study).Prevalence of microalbuminuria in hypertensive patients and its associated cardiovascular risk in clinical cardiology: Moroccan results of the global i-SEARCH survey - a sub-analysis of a survey with 21,050 patients in 26 countries worldwide.Microalbuminuria--a biomarker of renal microvascular disease.Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA).Influence of chronic kidney disease on cardiac structure and function.Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time.Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.Prevalence and distribution of (micro)albuminuria in toddlers.Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients.Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.Presence of albuminuria predicts left ventricular mass in patients with chronic systemic arterial hypertension.NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.Arterial Destiffening in Previously Untreated Mild Hypertensives After 1 Year of Routine Clinical Management.Left ventricular hypertrophy and proteinuria in patients with essential hypertension in Andkhoy, Afghanistan.Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population
P2860
Q24810969-E3AE5A79-545E-490F-9F5F-E1E98C39E6BAQ33610694-661ADE09-19B8-492B-87EE-B8C182D6BFE0Q34849534-C5892DFF-977B-4200-A7F1-5C18BE19A272Q35615423-E271183C-F395-4045-84B5-BD0FD7CC8AB7Q36737143-BC4FB24F-BD63-4C71-9E75-DD004327C789Q37011183-8F399069-5795-40D0-A5C7-DB84B692D749Q37041653-646A9E8A-1B27-4F2D-8AC1-6B80223BD45EQ37391460-4F8AC863-6C3A-4A5C-9EDC-DDD0B4D929A6Q37441011-9E51E900-775C-4953-837B-FEAF32C08BD2Q38550979-8DFF8FAC-C991-4180-ADE1-069CCC1CEBB2Q39165618-808F3DB0-954A-4E27-8E9B-C609C8214609Q39256344-CAD19A25-89B6-4DD2-9D0E-5A47966061FFQ40721152-4938D371-4A30-46E2-882F-2041B23CE147Q41020813-FA29F0E7-C428-4BCE-93AF-9DDC57C1022EQ42373709-A0D387A7-FF16-4ADE-96A9-15D85D115562Q43080316-93CEC02F-43AC-4936-8189-2A3586711C2EQ44930754-02B95A29-07FA-4064-90FA-225F3FB97ECFQ44990820-19255DB1-926C-4686-83CD-0528E64C1275Q46777802-1B60D331-6690-4140-AEAC-2E0D782523F2Q49132717-5F117280-09D2-4079-AB03-761AAA66D451Q51001130-7F31327E-2403-4D5E-97DA-ED68CF9E2358Q55268289-1620642B-D4C6-4F69-8CE3-56F3E4ECD1A7Q57315165-9603F57B-DD94-46DF-B946-79A7CE82B898
P2860
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@en
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@nl
type
label
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@en
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@nl
prefLabel
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@en
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@nl
P2093
P50
P356
P1476
Urine albumin/creatinine ratio ...... ention for Endpoint Reduction.
@en
P2093
Carl E Mogensen
Eva Gerdts
Hans Ibsen
Jackson T Wright
Jonathan N Bella
Knut Borch-Johnsen
Kristian Wachtell
Michael H Olsen
Tapio Aalto
Vasilios Papademetriou
P304
P356
10.1067/MHJ.2002.119895
P407
P577
2002-02-01T00:00:00Z